Baird Reiterates Neutral Rating on Elevance Health Inc. (ELV)

Market Context

Elevance Health Inc. operates in the Healthcare sector. The stock currently trades at $372.85 with a market capitalization of $80.0B. The stock has gained 18.3% over the past 52 weeks.

Analyst coverage from Baird provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Elevance Health Inc..

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Elevance Health Inc.

Among the 10 most recent ratings: 7 Buy, 3 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Jul 16, 2026	Wells Fargo	Overweight	N/A
Jul 16, 2026	RBC Capital	Sector Perform	N/A
Jul 16, 2026	Guggenheim	Buy	N/A
Jul 16, 2026	Barclays	Overweight	N/A
Jul 16, 2026	Baird	Neutral	N/A

Related Tools: Analyst Ratings Dashboard | View ELV Stock Page